Delivery Order SPE2DP16D0009-0063
- Not listed
- This firm fixed-price delivery order contract was awarded by the Defense agency Medical Supply Chain to Glaxosmithkline, LLC for the supply of the antiviral medication zanamivir for inhalation. The $1,532,034 contract has a completion date of December 15, 2016 and was not set aside for any special designation. Glaxosmithkline, a pharmaceutical company that provides vaccines, antivirals, and other products to government agencies, has received multiple federal contracts and grants to support...
- This $230,614.40 firm fixed price delivery order was awarded by the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline, to provide the antiviral medication zanamivir. The contract has a completion date of February 19, 2019 and was not set aside for any special business designation. Glaxosmithkline is a major pharmaceutical company that supplies vaccines, antivirals, and other medical countermeasures to federal agencies including the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC, a pharmaceutical company, for the supply of the antiviral medication zanamivir. The contract has a ceiling value of $80,651.20 and a completion date of February 19, 2019. The contract is not set aside for any particular business type. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies, including the Departments...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company, to provide the antiviral medication zanamivir. The $263,537.64 contract has a completion date of December 6, 2017 and does not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products to U.S. government agencies, including influenza vaccines, COVID-19 treatments, and other antiviral...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to GlaxoSmithKline, LLC to provide the antiviral medication zanamivir. The contract has a potential value of $289,864 and a completion date of February 19, 2019. GlaxoSmithKline, a foreign-owned for-profit pharmaceutical company, has provided a range of pharmaceutical goods and services to U.S. government agencies through various federal contract and grant awards, including...
- This is a $541,800.00 firm fixed price delivery order awarded to Glaxosmithkline, LLC by the Defense Logistics Agency Troop Support Medical for the supply of the antiviral medication zanamivir. The contract has a performance period ending on March 18, 2024. Glaxosmithkline, a foreign-owned pharmaceutical firm, is the prime contractor and has provided a range of medical countermeasures like vaccines and antivirals to U.S. government agencies through both contracts and grants in the past. This...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Glaxosmithkline, LLC for the antiviral medication zanamivir. The $196,885.60 contract has a performance location at Research Triangle Park, North Carolina and a completion date of February 19, 2019. The contract was not set aside for any special program. Glaxosmithkline is a foreign-owned, for-profit pharmaceutical company that provides a range of vaccines, antivirals, and other...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline, a foreign-owned, for-profit pharmaceutical company. The contract is for the supply of zanamivir, an antiviral medication, with a potential value of $162,184.00. The contract does not have a set-aside designation and the place of performance is Research Triangle Park, North Carolina. Glaxosmithkline has provided a...
- This federal contract award was issued by the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The $331,245.90 firm fixed price delivery order is for the antiviral medication zanamivir. There is no set-aside designation for this award. Glaxosmithkline has held other federal contracts and grants,...
- This is a $157,500.00 firm fixed price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline, for the pharmaceutical product zanamivir for inhalation. The contract has a completion date of March 18, 2024 and was awarded on August 29, 2023. Glaxosmithkline is a major pharmaceutical company that provides a range of drugs and vaccines to U.S. government agencies through federal contracts and grants. This...
- SPE2DP16D0009Indefinite Delivery Contract
- SPE2DP16D0009-0063Delivery Order
This is a delivery order awarded to Glaxosmithkline, LLC (doing business as Glaxosmithkline) by the Defense Medical Logistics Command, a subcomponent of the Defense Logistics Agency, for the purchase of the antiviral medication zanamivir. The $112,140.72 firm fixed price contract has an ultimate completion date of December 14, 2016 and was awarded on September 15, 2016. The contract is not designated as a set-aside. Glaxosmithkline is a pharmaceutical company that provides a range of products and services to U.S. government agencies, including vaccines, antiviral medications, and drug development support. The company holds multiple federal contract vehicles for pharmaceutical goods, and has also participated as a subcontractor on a large Department of Defense contract for COVID-19 monoclonal antibody therapeutics.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
J&A302-1SPE2DP16D0009 | SPE2DP-16-R-0005 | Defense Logistics Agency Land and Maritime | Limited / Sole Source Justification 3/3 | 9/16/16, 7:01 AM | |
Relenza/Zanamivir | SPE2DP-16-R-0005 | Defense Logistics Agency Land and Maritime | Award Notice 2/3 | 9/13/16, 8:05 AM | |
Zanamivir for Inhalation | SPE2DP-16-R-0005 | Defense Logistics Agency Troop Support Medical | Award Notice 1/3 | 3/29/16, 2:45 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Other Administrative Action | ($206k) | 10/13/16 | |
| Not listed | Not listed | $317.9k | 9/15/16 |